Savant bought 18-MC, we bought savant with 18-MC. Glick is on our board. They (savant) got a grant for trials but ran out of funding. Stephen Hurst the real CEO was owner of savant. Can't remember off top of my head how much the paid him or how many shares he got but it was a good amount.
Nothing much to discuss other than the drug works or it doesn't. That's what trials are for.